Indomethacin and ibuprofen preserve gastrocnemius muscle mass in mice bearing the colon‐26 adenocarcinoma
- 6 May 2004
- journal article
- Published by Wiley in Research in Nursing & Health
- Vol. 27 (3) , 174-184
- https://doi.org/10.1002/nur.20019
Abstract
Skeletal muscle wasting is a prominent feature of cancer cachexia and involves decreased muscle protein synthesis and increased activity of the ubiquitin‐proteasome pathway of protein degradation. We report that both indomethacin and ibuprofen improved body weight and weight of the gastrocnemius muscle in tumor‐bearing mice. Ibuprofen increased the soluble protein content of the muscle without affecting muscle levels of phosphorylated p70 S6 kinase, a ribosomal kinase involved in protein synthesis. Paradoxically, indomethacin increased levels of ubiquitin‐conjugated proteins. Further study is needed to understand the mechanism of action by which indomethacin and ibuprofen preserve body weight and muscle mass in the tumor‐bearing mice. The data suggest that ibuprofen may have beneficial effects in the treatment of cancer cachexia. © 2004 Wiley Periodicals, Inc. Res Nurs Health 27:174–184, 2004Keywords
This publication has 53 references indexed in Scilit:
- Cancer cachexia: the molecular mechanismsThe International Journal of Biochemistry & Cell Biology, 2003
- Role of NF-κB and cytokine in experimental cancer cachexiaWorld Journal of Gastroenterology, 2003
- Altered expression of skeletal muscle myosin isoforms in cancer cachexiaAmerican Journal of Physiology-Cell Physiology, 2002
- Polyunsaturated fatty acids, inflammation and immunityEuropean Journal of Clinical Nutrition, 2002
- Management of muscle wasting in cancer-associated cachexiaCancer, 2001
- Regulation of skeletal-muscle–protein turnover in cancer-associated cachexiaNutrition, 2000
- Symptom and quality of life survey of medical oncology patients at a Veterans Affairs medical centerCancer, 2000
- Phosphorylation of p70S6kcorrelates with increased skeletal muscle mass following resistance exerciseAmerican Journal of Physiology-Cell Physiology, 1999
- Anti-interleukin-6 receptor antibody prevents muscle atrophy in colon-26 adenocarcinoma-bearing mice with modulation of lysosomal and ATP-ubiquitin-dependent proteolytic pathwaysInternational Journal of Cancer, 1996
- Inhibition of lipolysis and muscle protein degradation by epa in cancer cachexiaNutrition, 1996